About this trial
In this study, we are trying to see if vitamin B6 can minimize the amplified blood pressure response to exercise following ischemia-reperfusion injury. We are interested in a protein called P2X3, of which function can be blocked by vitamin B6, in the neurons of our nervous system. It is very important for blood pressure regulation. We would like to see if the P2X3 plays a role in patients' rising blood pressure during exercise. The results of the proposed studies will provide a base for those two potential economic and non-invasive inventions to improve the overall health and well-being of PAD patients.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Are males and females at least 21- 70 years of age (inclusive)
Capable of giving informed consent
Are of any race or ethnicity
Can communicate in English
Disqualifiers
< 21 years of age or > 70 years of age
Pregnant or nursing woman
Prisoners or institutionalized individuals unable to consent
Decisional impairment
Trial design
Parallel
Treatments tested in this trial
Vitamin B6 25 MG
DrugVitamin B6 25 mg/day will be given for up to 31 days.
Vitamin B6 50 MG
DrugVitamin B6 50 mg/day will be given for up to 31 days.
Vitamin B6 100 MG
DrugVitamin B6 100 mg/day will be given for up to 31 days.
Placebo
DrugPlacebo capsule will be given for up to 31 days.
Treatment groups
Trial outcomes
Primary outcomes
baseline blood pressure in mmHg
Second visit blood pressure in mmHg
baseline heart Rate in beats per minute
Second visit heart Rate in beats per minute
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Milton S. Hershey Medical Center
Lead sponsor
American Heart Association
Collaborator
This trial is not recruiting at the moment. You can still explore other options: